Next FDA chief increases drug approvals by 15% in 2027

Republican-led FDA commissions have historically approved more drugs than Democratic-led ones. If the next commissioner aligns with industry-friendly policies, approvals could rise significantly. Analysts expect a 10-20% uptick in new drug approvals compared to 2026 levels.

Implied probability (Yes)

70%